Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -0.02% | 64.35 | 1.0% | $559.99m | |
| AMGN | Amgen, Inc. | 1.21% | 227.56 | 1.3% | $484.23m | |
| BIIB | Biogen, Inc. | -0.15% | 281.54 | 1.4% | $395.32m | |
| ILMN | Illumina, Inc. | 0.29% | 315.18 | 3.5% | $328.68m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.45% | 233.02 | 1.9% | $278.06m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.15% | 343.55 | 2.6% | $250.35m | |
| EXAS | EXACT Sciences Corp. | -0.01% | 90.70 | 24.0% | $228.33m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.09% | 108.14 | 2.0% | $180.53m | |
| A | Agilent Technologies, Inc. | 1.10% | 88.14 | 1.6% | $138.48m | |
| INCY | Incyte Corp. | -1.11% | 75.61 | 2.5% | $128.22m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.74% | 119.98 | 14.6% | $117.98m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.84% | 86.61 | 4.3% | $113.52m | |
| SGEN | Seattle Genetics, Inc. | -0.91% | 111.90 | 6.1% | $106.85m | |
| DERM | Dermira, Inc. | -0.24% | 18.76 | 3.8% | $85.83m | |
| BLUE | bluebird bio, Inc. | 0.66% | 84.51 | 14.2% | $84.94m |
Company Profile
Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities includes recruiting personnel, conducting research and development, including clinical trials, raising capital and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA.